Regeneron’s coronavirus antibody cocktail therapy against COVID-19, famously used to treat president Donald Trump, has hit a safety issue after independent safety experts recommended it should ...

Regeneron has said it has begun clinical trials of its antibody cocktail therapy for COVID-19, as pharma companies continue their search for treatments as the pandemic continues to cause havoc ...

A COVID-19 treatment from Regeneron Pharmaceuticals that consists of a pair of ... In lab experiments, the researchers found that nine times fewer antibodies within the cocktail bind to B.1.351’s ...

Why is his proclamation of Regeneron's unproven and experimental antibody cocktail so dangerous? What is commission bias? With some updates about hydroxychloroquine and vitamin D.

Regeneron is also moving forward with antibody cocktails in infectious diseases; it gained approval for Ebola cocktail REGN-EB3 in October 2020 and authorization for COVID-19 cocktail REGN-COV in ...

The company will push through with an accelerated approval application for odronextamab in follicular lymphoma, leaving ...

While Regeneron doesn’t make vaccines specifically, its monoclonal antibody therapy provides a "passive vaccine" effect, temporarily protecting against infections. Dupixent Could Gain 30% More U ...

Sanofi and Regeneron’s blockbuster biologic Dupixent ... Dupixent, a fully human monoclonal antibody, inhibits the signalling of interleukin-4 (IL-4) and interleukin-13 (IL-13) pathways ...

Regeneron also recently won FDA approval for Inmazeb, another antibody cocktail and the first-ever drug proved to be effective in treating Ebola. Those innovations have helped boost Regeneron’s ...

Roivant earns top recognition in the science and technology category of Fast Company's Best Workplaces for Innovators 2023. Best Workplaces for Innovators 2023: Sustainability Holcim earns top ...